About Flag Therapeutics
Flag Therapeutics is a company based in Raleigh (United States) founded in 2013. Flag Therapeutics has raised $1.37 million across 5 funding rounds from investors including HHS and NCBiotech. Flag Therapeutics offers products and services including FLAG-003 and FLAG-094.
- Headquarter Raleigh, United States
- SectorsHealthcare
- Website flagtherapeutics.com
- Social LinkedIn X
- Legal Name Flag Therapeutics, Inc.
- Total Equity Funding$1.37M (USD)
in 5 rounds
- Latest Funding Round$72.5K (USD), Seed
Jun 2019
- InvestorsHHS
& 1 more
Products & Services of Flag Therapeutics
Flag Therapeutics offers a comprehensive portfolio of products and services, including FLAG-003 and FLAG-094.
Small molecule treatment for DIPG and GBM cancers
Small molecule therapy for endometrial ovarian cancer
Funding Insights of Flag Therapeutics
Flag Therapeutics has successfully raised a total of $1.37M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $72.5 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.37M
- Total Rounds 5
- Last Round Seed — $72,500
- First Round $50,000
(May 2014)
- Investors Count 2
All 5 funding rounds of Flag Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Flag Therapeutics
Flag Therapeutics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and NCBiotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are incubated and funded in North Carolina. | 1984 | ncbiotech.org | Durham, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Flag Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Flag Therapeutics
1 people are tracked at Flag Therapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Frank L Sorgi | President & CEO | Leadership |
Complete people profiles for Flag Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Flag Therapeutics
3 dated milestones of Flag Therapeutics across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Flag Therapeutics is founded.
- Funding First funding round of $50K.
- Funding Latest funding round, Seed, of $72K.
Web traffic of Flag Therapeutics
Websites that share an audience with Flag Therapeutics (flagtherapeutics.com).
Websites whose visitors overlap most with Flag Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
farmaciacamacho.es | farmaciacamacho.es | 100% | – | #9,218,959 | – |
Latest news on Flag Therapeutics
Complete news archive for Flag Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Flag Therapeutics
10 companies that operate in the same segment as Flag Therapeutics (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Flag Therapeutics
Flag Therapeutics was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Flag Therapeutics is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Flag Therapeutics is a funded company, having raised a total of $1.37M across 5 funding rounds to date. The company's 1st funding round was a Debt – Venture of $50K, raised on May 2014.
Flag Therapeutics was founded in 2013 in Raleigh, United States, within the biotechnology sector focused on oncology. Small molecule therapeutics are developed using a proprietary platform that produces water-soluble compounds designed to target and bind cancer cells. The pipeline includes FLAG-003, a lead candidate for treating Diffuse Intrinsic Pontine Glioma and glioblastoma multiforme, addressing unmet needs in difficult cancers.
Flag Therapeutics offers FLAG-003 and FLAG-094.
Flag Therapeutics operates through Flag Therapeutics, Inc..